202 related articles for article (PubMed ID: 7591141)
21. Coinfection with Borrelia burgdorferi sensu stricto and Borrelia garinii alters the course of murine Lyme borreliosis.
Hovius JW; Li X; Ramamoorthi N; van Dam AP; Barthold SW; van der Poll T; Speelman P; Fikrig E
FEMS Immunol Med Microbiol; 2007 Mar; 49(2):224-34. PubMed ID: 17328756
[TBL] [Abstract][Full Text] [Related]
22. Characterization of the protective antibody response to Borrelia burgdorferi in experimentally infected LSH hamsters.
Schmitz JL; Schell RF; Lovrich SD; Callister SM; Coe JE
Infect Immun; 1991 Jun; 59(6):1916-21. PubMed ID: 2037352
[TBL] [Abstract][Full Text] [Related]
23. Characterization of the protective borreliacidal antibody response in humans and hamsters after vaccination with a Borrelia burgdorferi outer surface protein A vaccine.
Padilla ML; Callister SM; Schell RF; Bryant GL; Jobe DA; Lovrich SD; DuChateau BK; Jensen JR
J Infect Dis; 1996 Oct; 174(4):739-46. PubMed ID: 8843211
[TBL] [Abstract][Full Text] [Related]
24. Cutting edge: T cell-mediated pathology in murine Lyme borreliosis.
McKisic MD; Redmond WL; Barthold SW
J Immunol; 2000 Jun; 164(12):6096-9. PubMed ID: 10843657
[TBL] [Abstract][Full Text] [Related]
25. Borreliacidal antibody production against outer surface protein C of Borrelia burgdorferi.
Rousselle JC; Callister SM; Schell RF; Lovrich SD; Jobe DA; Marks JA; Wieneke CA
J Infect Dis; 1998 Sep; 178(3):733-41. PubMed ID: 9728542
[TBL] [Abstract][Full Text] [Related]
26. Detection of borreliacidal antibodies in dogs after challenge with Borrelia burgdorferi-infected ixodes scapularis ticks.
Callister SM; Jobe DA; Schell RF; Lovrich SD; Onheiber KL; Korshus JB
J Clin Microbiol; 2000 Oct; 38(10):3670-4. PubMed ID: 11015381
[TBL] [Abstract][Full Text] [Related]
27. Borreliacidal OspC antibodies specific for a highly conserved epitope are immunodominant in human lyme disease and do not occur in mice or hamsters.
Lovrich SD; Jobe DA; Schell RF; Callister SM
Clin Diagn Lab Immunol; 2005 Jun; 12(6):746-51. PubMed ID: 15939749
[TBL] [Abstract][Full Text] [Related]
28. CD4+ cell-derived interleukin-17 in a model of dysregulated, Borrelia-induced arthritis.
Hansen ES; Johnson ME; Schell RF; Nardelli DT
Pathog Dis; 2016 Oct; 74(7):. PubMed ID: 27549424
[TBL] [Abstract][Full Text] [Related]
29. Borrelia burgdorferi-infected, interleukin-6-deficient mice have decreased Th2 responses and increased lyme arthritis.
Anguita J; Rincón M; Samanta S; Barthold SW; Flavell RA; Fikrig E
J Infect Dis; 1998 Nov; 178(5):1512-5. PubMed ID: 9780277
[TBL] [Abstract][Full Text] [Related]
30. Molecular characterization of the OspA(161-175) T cell epitope associated with treatment-resistant Lyme arthritis: differences among the three pathogenic species of Borrelia burgdorferi sensu lato.
Drouin EE; Glickstein LJ; Steere AC
J Autoimmun; 2004 Nov; 23(3):281-92. PubMed ID: 15501399
[TBL] [Abstract][Full Text] [Related]
31. CD4+ T cells promote antibody production but not sustained affinity maturation during Borrelia burgdorferi infection.
Elsner RA; Hastey CJ; Baumgarth N
Infect Immun; 2015 Jan; 83(1):48-56. PubMed ID: 25312948
[TBL] [Abstract][Full Text] [Related]
32. Serum-mediated resolution of Lyme arthritis in mice.
Barthold SW; deSouza M; Feng S
Lab Invest; 1996 Jan; 74(1):57-67. PubMed ID: 8569198
[TBL] [Abstract][Full Text] [Related]
33. Arthritogenicity of Borrelia burgdorferi and Borrelia garinii: comparison of infection in mice.
Craig-Mylius KA; Lee M; Jones KL; Glickstein LJ
Am J Trop Med Hyg; 2009 Feb; 80(2):252-8. PubMed ID: 19190223
[TBL] [Abstract][Full Text] [Related]
34. Infectivity and early antibody response to Borrelia burgdorferi sensu lato isolated in Japan in outbred mice.
Masuzawa T; Kurita T; Kawabata H; Muramatsu K; Uchikawa K; Yanagihara Y
Microbiol Immunol; 1994; 38(8):621-7. PubMed ID: 7799835
[TBL] [Abstract][Full Text] [Related]
35. Variable serum immunoglobulin responses against different Borrelia burgdorferi sensu lato species in a population at risk for and patients with Lyme disease.
Bunikis J; Olsén B; Westman G; Bergstroöm S
J Clin Microbiol; 1995 Jun; 33(6):1473-8. PubMed ID: 7650170
[TBL] [Abstract][Full Text] [Related]
36. Destructive arthritis in vaccinated interferon gamma-deficient mice challenged with Borrelia burgdorferi: modulation by tumor necrosis factor alpha.
Christopherson JA; Munson EL; England DM; Croke CL; Remington MC; Molitor ML; DeCoster DJ; Callister SM; Schell RF
Clin Diagn Lab Immunol; 2003 Jan; 10(1):44-52. PubMed ID: 12522038
[TBL] [Abstract][Full Text] [Related]
37. CD4(+) CD25(+) T cells prevent arthritis associated with Borrelia vaccination and infection.
Nardelli DT; Cloute JP; Luk KH; Torrealba J; Warner TF; Callister SM; Schell RF
Clin Diagn Lab Immunol; 2005 Jun; 12(6):786-92. PubMed ID: 15939755
[TBL] [Abstract][Full Text] [Related]
38. Lyme borreliosis in transgenic mice tolerant to Borrelia burgdorferi OspA or B.
Fikrig E; Tao H; Chen M; Barthold SW; Flavell RA
J Clin Invest; 1995 Oct; 96(4):1706-14. PubMed ID: 7560061
[TBL] [Abstract][Full Text] [Related]
39. Resistance to tick-borne spirochete challenge induced by Borrelia burgdorferi strains that differ in expression of outer surface proteins.
Kurtti TJ; Munderloh UG; Hughes CA; Engstrom SM; Johnson RC
Infect Immun; 1996 Oct; 64(10):4148-53. PubMed ID: 8926082
[TBL] [Abstract][Full Text] [Related]
40. Seroprotective groups of Lyme borreliosis spirochetes from North America and Europe.
Lovrich SD; Callister SM; Lim LC; DuChateau BK; Schell RF
J Infect Dis; 1994 Jul; 170(1):115-21. PubMed ID: 8014485
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
